Rachel A. Toroni

532 total citations
9 papers, 425 citations indexed

About

Rachel A. Toroni is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Cell Biology. According to data from OpenAlex, Rachel A. Toroni has authored 9 papers receiving a total of 425 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 2 papers in Pathology and Forensic Medicine and 2 papers in Cell Biology. Recurrent topics in Rachel A. Toroni's work include Ubiquitin and proteasome pathways (3 papers), Angiogenesis and VEGF in Cancer (3 papers) and Wnt/β-catenin signaling in development and cancer (3 papers). Rachel A. Toroni is often cited by papers focused on Ubiquitin and proteasome pathways (3 papers), Angiogenesis and VEGF in Cancer (3 papers) and Wnt/β-catenin signaling in development and cancer (3 papers). Rachel A. Toroni collaborates with scholars based in United States, Australia and Germany. Rachel A. Toroni's co-authors include Randall T. Moon, Andy J. Chien, Rima M. Kulikauskas, Olivia M. Lucero, Sunil Badve, Travis L. Biechele, Yesim Gökmen‐Polar, Richard G. James, Jamie N. Anastas and David W. Dawson and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Cancer Research.

In The Last Decade

Rachel A. Toroni

9 papers receiving 420 citations

Peers

Countries citing papers authored by Rachel A. Toroni

Since Specialization

Citations

This map shows the geographic impact of Rachel A. Toroni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rachel A. Toroni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rachel A. Toroni more than expected).

Fields of papers citing papers by Rachel A. Toroni

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rachel A. Toroni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rachel A. Toroni. The network helps show where Rachel A. Toroni may publish in the future.

Co-authorship network of co-authors of Rachel A. Toroni

This figure shows the co-authorship network connecting the top 25 collaborators of Rachel A. Toroni. A scholar is included among the top collaborators of Rachel A. Toroni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rachel A. Toroni. Rachel A. Toroni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

#	Work	Indexed citations
1	Gene Expression Analysis Reveals Distinct Pathways of Resistance to Bevacizumab in Xenograft Models of Human ER-Positive Breast Cancer 2014 ·Publisher ·Yesim Gökmen‐Polar, Chirayu Goswami, Rachel A. Toroni, Kerry L. Sanders, Rutika Mehta, (unknown), Bogdan Tanasă, Changyu Shen, Lang Li, Mircea Ivan, Sunil Badve, George W. Sledge	2
2	Gene Expression Analysis Reveals Distinct Pathways of Resistance to Bevacizumab in Xenograft Models of Human ER-Positive Breast Cancer 2014 ·Journal of Cancer ·Yesim Gökmen‐Polar, Chirayu Goswami, Rachel A. Toroni, Kerry L. Sanders, Rutika Mehta, (unknown), Bogdan Tanasă, Changyu Shen, Lang Li, Mircea Ivan, Sunil Badve, George W. Sledge	10
3	WNT5A enhances resistance of melanoma cells to targeted BRAF inhibitors 2014 ·Journal of Clinical Investigation ·Jamie N. Anastas, Rima M. Kulikauskas, Tigist Y. Tamir, Helen Rizos, Georgina V. Long, Erika M. von Euw, (unknown), (unknown), Lauren E. Haydu, Rachel A. Toroni, Olivia M. Lucero, Andy J. Chien, Randall T. Moon	129
4	Protein Kinase PKN1 Represses Wnt/β-Catenin Signaling in Human Melanoma Cells 2013 ·Journal of Biological Chemistry ·Richard G. James, (unknown), Rima M. Kulikauskas, (unknown), (unknown), Rachel A. Toroni, Travis L. Biechele, Jason D. Berndt, Priska D. von Haller, Jimmy K. Eng, Alejandro Wolf‐Yadlin, Andy J. Chien, Randall T. Moon	28
5	Investigational drug MLN0128, a novel TORC1/2 inhibitor, demonstrates potent oral antitumor activity in human breast cancer xenograft models 2012 ·Breast Cancer Research and Treatment ·Yesim Gökmen‐Polar, Yi Liu, Rachel A. Toroni, Kerry L. Sanders, Rutika Mehta, Sunil Badve, Christian Rommel, George W. Sledge	69
6	WLS inhibits melanoma cell proliferation through the β‐catenin signalling pathway and induces spontaneous metastasis 2012 ·EMBO Molecular Medicine ·(unknown), Jamie N. Anastas, Rachel A. Toroni, Michi M. Shinohara, Jamie M. Goodson, Anja‐Katrin Bosserhoff, Andy J. Chien, Randall T. Moon	26
7	Wnt/β-Catenin Signaling and AXIN1 Regulate Apoptosis Triggered by Inhibition of the Mutant Kinase BRAF ^V600E in Human Melanoma 2012 ·Science Signaling ·Travis L. Biechele, Rima M. Kulikauskas, Rachel A. Toroni, Olivia M. Lucero, (unknown), Richard G. James, (unknown), David W. Dawson, Randall T. Moon, Andy J. Chien	122
8	Dual targeting of EphA2 and ER restores tamoxifen sensitivity in ER/EphA2-positive breast cancer 2010 ·Breast Cancer Research and Treatment ·Yesim Gökmen‐Polar, Rachel A. Toroni, Barbara A. Hocevar, Sunil Badve, Qianqian Zhao, Changyu Shen, Elizabeth Bruckheimer, Michael S. Kinch, Kathy D. Miller	38
9	Abstract 4490: INK128, a novel TORC1/2 inhibitor, demonstrates potent oral antitumor activity in a VEGF-reinforced murine model of breast cancer and enhances efficacy of bevacizumab 2010 ·Cancer Research ·Yesim Gökmen‐Polar, Yi Liu, Rachel A. Toroni, Kerry L. Sanders, (unknown), Rutika Mehta, Sunil Badve, Christian Rommel, George W. Sledge	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact